Conditions: Neoplasms
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 59
Healthy volunteers: no

Brief summary:
The primary objective of this trial is to identify the maximum tolerated dose (MTD) of BI 6727 in Asian cancer patients, and to provide safety data in terms of drug-related adverse events.

Detailed description:

Arms:
arm 1: Schedule A

Interventions: intervention 1: BI 6727
Intervention descriptions: intervention 1: Dose level 1

Protocol document: